NAD+ precursors can raise blood NAD+, but this is not proof that they slow ageing or extend human life. Changing a biochemical measurement is different from improving long-term health. 1

NAD+ Biology and Function

Nicotinamide adenine dinucleotide, or NAD+, helps cells transfer electrons during energy metabolism. It cycles between NAD+ and NADH in processes including glycolysis and the citric acid cycle. 2

NAD+ also supports sirtuins, enzymes involved in metabolic regulation and stress responses, and PARPs, which participate in DNA-damage responses. 2

There is an important distinction: energy reactions recycle NAD+ and NADH, whereas NAD+-consuming enzymes break the molecule down. Cells must replenish it, including through pathways that recycle nicotinamide. 1 2

This makes NAD+ availability biologically important. It does not mean that supplying more precursor will improve every NAD+-dependent process. 2

Age-Related NAD+ Decline

NAD+ decline is not a universal human ageing rule. Results differ between tissues, populations and measurement methods. The familiar claim of a 50% fall by middle age is not a reliable personal estimate. 3

A 2026 study across seven human cohorts found whole-blood NAD+ remained stable with age and across the lifestyle interventions examined. That does not rule out changes in muscle, brain or other tissues. 3

Researchers investigate both altered synthesis and increased consumption. In mouse experiments, signals from senescent cells increased CD38 activity in immune cells, contributing to tissue NAD+ depletion. 4

This links inflammation, cellular senescence and NAD+ metabolism mechanistically. It does not establish which process limits NAD+ in an individual, or show that supplements reverse human ageing. 4

NMN vs NR as Precursors

Nicotinamide mononucleotide, NMN, and nicotinamide riboside, NR, both feed NAD+ synthesis. NR can be converted to NMN before NAD+ formation, but oral metabolism also involves breakdown and recycling. 1

Being one step closer in a pathway is therefore not proof that NMN is better absorbed or more effective. The relevant test is what happens in people. 1

A 2026 randomised, open-label study analysed 65 adults across four groups. Taking 1,000 mg daily of either NMN or NR for 14 days produced similar increases in whole-blood NAD+. 1

Another 2026 study compared both precursors in six healthy volunteers over eight days and found a larger blood NAD response with NR. Neither comparison establishes superior health or longevity benefits. 5

The latter study subsequently gave NR for four weeks to six healthy people and six people with Parkinson’s disease. Brain NAD measurements increased in the pooled analysis, but individual responses varied. 5

That is evidence of a tissue biochemical response, not proof of improved cognition or slower ageing. This small, open-label study was designed to examine NAD kinetics. 5

Current Evidence Limitations

Human findings are not limited to blood tests, but specific benefits should not be inflated into general anti-ageing claims. Two trials illustrate the distinction. 2 6

In a double-blind trial, 25 postmenopausal women with prediabetes and overweight or obesity completed ten weeks of NMN or placebo. The NMN dose was 250 mg daily. 6

NMN improved muscle insulin sensitivity, but not fasting glucose, body composition or muscle NAD+ concentration. The result does not establish diabetes prevention or benefits in other populations. 6

In a crossover trial, 12 older men took 1,000 mg of NR daily for 21 days. Muscle levels of related NAD+ metabolites increased, but muscle NAD+ itself and mitochondrial function did not significantly improve. 2

These studies show why the outcome matters. Blood levels, tissue metabolites, insulin sensitivity and long-term disease risk are different endpoints, not interchangeable evidence of rejuvenation. 2 6

Dosing and Safety

The amounts above describe research, not a recommended supplement schedule. These studies do not establish an optimal dose, formulation or treatment duration for healthy ageing. 1 5 6

Short-term tolerability also cannot establish safety over years. A small trial can miss uncommon harms and cannot answer every question about use alongside other treatments. 5 6

Before starting, discuss the exact product and your medicines with your GP or pharmacist. Include other supplements, and do not alter prescribed treatment to accommodate an NAD+ product. 7

If you develop symptoms after starting a product, seek advice rather than assuming they are a harmless adjustment. 7

Practical Considerations

Prioritise activity for its established benefits, not a promised NAD+ increase. Walking, cycling and strength work can form a sustainable routine suited to your ability and health. 8

Make regular meals, adequate sleep and manageable training your starting plan. Avoid adding restrictive eating rules or supplement costs simply to chase a laboratory number.

The 2026 whole-blood study challenges using NAD+ results to judge lifestyle success. A higher reading is not a validated target for slower ageing. 3

For monitoring, ask what a test would change before buying it. Discuss relevant health checks with your clinician, and track practical goals such as training consistency rather than treating every change as a supplement effect.

For related context, read about biological age measurement and time-restricted eating.

If you want support with nutrition habits, explore our Longevity Programme.